Rocuronium Bromide Injection
Product Images NDC 71872-7262

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Rocuronium Bromide (NDC 71872-7262). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medical Purchasing Solutions, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

71872-7262-01.pdp (71872 7262 01)

71872-7262-01.pdp (71872 7262 01)
Drug information panel for Rocuronium Bromide Injection, 50 mg/5 mL multiple dose vial, for intravenous use. Includes warnings about respiratory arrest, dosage storage instructions (refrigeration required, do not freeze), components per mL, and distributor details: Baxter Healthcare Corporation and Medical Purchasing Solutions, Scottsdale, AZ.*
FDA Label Image

Rocuronium Structural Formula (Image 01)

Rocuronium Structural Formula (Image 01)
Chemical structure of rocuronium bromide, showing its molecular framework including a steroidal backbone, quaternary ammonium group, and bromide ion.*
FDA Label Image

Figure 1 (Rocuronium Function of Dose)

Figure 1 (Rocuronium Function of Dose)
A scatter plot with box plots illustrating dosage in mg/kg on the x-axis and corresponding time in minutes on the y-axis. The chart compares Rocuronium Bromide injection times across three age groups: 18-64 years, 65 years and older, and 1-12 years, at various dosage levels from approximately 0.45 to 1.2 mg/kg.*
FDA Label Image

Figure 2 (Rocuronium Function of Dose)

Figure 2 (Rocuronium Function of Dose)
A box plot chart showing data distribution of a variable measured in minutes on the y-axis, compared across different dose levels (0.45 to 0.8 mg/kg) and age groups on the x-axis, including 18-64 years, 65 years and older, 3 months to 1 year, and 1 to 12 years.*
FDA Label Image

Figure 3 (Rocuronium Clinical Durations)

Figure 3 (Rocuronium Clinical Durations)
A line graph depicting the relationship between dose number (x-axis) and minutes (y-axis) for Rocuronium Bromide at two dosage levels, 0.1 mg/kg and 0.15 mg/kg. The chart includes sample sizes (N=29 for 0.1 mg/kg and N=13 for 0.15 mg/kg) and shows the time progression over five dose numbers.*
FDA Label Image

Rocuronium Representative Container Label 50 mg 43066-007-10 (Image 05)

Rocuronium Representative Container Label 50 mg 43066-007-10 (Image 05)
Label for Rocuronium Bromide Injection 50 mg/5 mL (10 mg/mL) intravenous injection in a 5 mL multiple dose vial. The label includes warnings that the product is a paralyzing agent for IV use only, and states it is sterile and nonpyrogenic. Distributed by Baxter Healthcare Corporation. The label also features NDC 43066-007-10, barcode, lot number, and expiration date fields.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.